NCT02742259View on ClinicalTrials.gov

Validation of the Prostate Cancer Assay - Beta+Pivotal

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

May 31, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

September 30, 2017

Conditions
Metastatic Prostate Cancer, CTC
Interventions
DEVICE

Blood Draw

Blood draws only - non-diagnostic, non-treatment

Sponsors

Lead Sponsor

Celsee Diagnostics
All Listed Sponsors
lead

Celsee Diagnostics

INDUSTRY